Why the study?
Does I.C.I. 50172 reduce ventricular rate in patients with heart failure or postoperative valve replacement and refractory tachyarrhythmias?
Does I.C.I. 50172 reduce ventricular rate in patients with heart failure or postoperative valve replacement and refractory tachyarrhythmias?
Answers are grounded in this paper and cite their sources.
I.C.I. 50172 safely and effectively reduced rapid ventricular rates in patients with impaired myocardial function where conventional treatments failed.
I.C.I. 50172 was used to slow the ventricular rate when conventional treatment had failed in 19 patients. All were either in congestive cardiac failure or in the immediate postoperative period following valve replacement. The ventricular rate was controlled in seven out of eight patients with atrial fibrillation, in six out of nine patients with supraventricular tachycardia, and in two patients with sinus rhythm. Important side-effects were not seen.
No takes yet. Share an insight, caveat, or question.
Gibson et al. (1968) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: